Pulmonary Embolism (PE) is a complex multifactorial syndrome characterized by a wide spectrum of symptoms, representing the third most common acute cardiovascular syndrome after myocardial infarction and stroke. While the diagnosis of PE has become routine clinical practice, its risk stratification remains challenging. Prediction of clinical outcomes of different PE phenotypes is a growing area of research exploring the role of biomarkers.
Evidence for the Interplay between Inflammation and Clotting System in the Pathogenetic Chain of Pulmonary Embolism: A Potential Therapeutic Target to Prevent Multi-organ Failure and Residual Thrombotic Risk
Giarratana D.Methodology
;Malatino L.
Conceptualization
2025-01-01
Abstract
Pulmonary Embolism (PE) is a complex multifactorial syndrome characterized by a wide spectrum of symptoms, representing the third most common acute cardiovascular syndrome after myocardial infarction and stroke. While the diagnosis of PE has become routine clinical practice, its risk stratification remains challenging. Prediction of clinical outcomes of different PE phenotypes is a growing area of research exploring the role of biomarkers.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
